VISTA, CALIF. (UPDATED Sept. 14, 6:05 p.m. ET) — In a significant portfolio expansion, holding company Providien LLC of Scottsdale, Ariz., acquired a majority interest in Integra Biotechnical LLC of Vista. Terms were not disclosed.
With annual sales of $25 million, Integra offers turnkey medical-device development and contract manufacturing, supply-chain and fulfillment services. Customers include well-known medical-device and pharmaceutical OEMs.
George Walker founded the business in 1997 and continues as Integra president and CEO.
Working with a geographically dispersed supplier base, Integra assembles or packages an array of infusion and drainage catheters for cardiac surgery and angiography procedures, Jeffrey Goble, Providien president and CEO, said in a Sept. 14 telephone interview. Other products include Huber needle sets and disposable infusion devices.
Integra employs about 600 in leased facilities in Tijuana, Mexico, that are certified under ISO 13485:2003 and 9001:2008. The site has 70,000 square feet of space, including 27,000 square feet for Class 8 clean room operations.
Fewer than 20 employees are located in a leased, 21,000-square-foot Vista facility for executive and distribution functions.
Providien completed the transaction June 30. The deal was not disclosed until Sept. 13.
Since its formation in June 2010, privately owned Providien has acquired thermoformer Specialty Manufacturing Inc. of San Diego; injection molder and assembler Plastics Engineering and Development Inc. of Carlsbad, Calif.; and PortO2vent oxygen-delivery-system maker Emergent Respiratory LLC, also of Carlsbad.
Adding Integra gives Providien “the ability to provide significant advantages to our customers,” Goble said.
Providien founders Charles Stroupe and Goble, along with Portland, Ore.-based private equity firm Endeavor Capital, provide funding for Providien acquisitions and operations. Stroupe is Providien chairman.
Including Integra, Providien operations have “sales north of $50 million” and more than 800 employees, Goble said. “We continue to search for additional great acquisitions,” he added.